Federal Ministry of Research, Technology and Space · Deutschland

KMU-innovativ: Medical technology (BMFTR)

Offen

Die Einreichungsfrist endet am 15. April 2027.

Frist: 15. April 2027 (in 151 Tagen)
Fördersumme: Bis zu 300.000 € pro Antragsteller
Förderquote: De-minimis route: up to 80% for micro and small companies, up to 70% for medium-sized (max. €300,000); otherwise GBER rates with SME bonuses
Wahrscheinliche Antragstellende: KMU / Start-ups, Unternehmen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber: Federal Ministry of Research, Technology and Space (BMFTR)
Referenz: KMU-innovativ: Medizintechnik
Zuletzt geprüft: 15. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Programmübersicht

High-risk research and pre-competitive development of innovative medical devices, in-vitro diagnostics and digital medical technologies, run by SMEs together with research, clinical and healthcare partners.

Wer kann sich bewerben?

SMEs, typically in collaborative projects with research institutions, clinical partners and healthcare organisations; in collaborative projects at least 50% of the requested funding must go to the participating SMEs. Results may only be exploited in Germany, the EEA or Switzerland.

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Zeitplan

Project outlines are due on 15 April and 15 October each year (next: 15 April 2027); late outlines may move to the next date.

So bewerben Sie sich

Check the project fits the guideline (medical devices, IVD or digital medical technology; companion diagnostics belong to KMU-innovativ: Biomedizin).
Form the collaboration of SMEs with research, clinical or healthcare partners.
Prepare the project outline in easy-Online (https://foerderportal.bund.de/easyonline) for the next cut-off; formal applications follow only on invitation.
Read the amendment of 20 October 2026 and contact the project management agency named there.

✓ Checked against the official call text on 2026-11-15 (BMFTR announcement KMU-innovativ: Medizintechnik (BAnz 06.02.2026) and amendment (BAnz 20.10.2026)).

From the call text

Who can apply: SMEs as defined by the EU, and mid-sized companies under the national rule (up to 1,000 employees, as defined in the guideline), working with research institutions, clinical partners and healthcare organisations.
Company stage: High-risk research and pre-competitive development of medical devices, in-vitro diagnostics or digital medical products (risk class I/A only if highly innovative).
Single applicant or consortium: Collaborative projects of SMEs with research, clinical and healthcare partners.
Where applicants must be based: As stated in the guideline.
Where to apply: Project outlines and formal applications through the federal easy-Online system (foerderportal.bund.de/easyonline); the project management agency named in the announcement handles questions.

Offizielle Quellen

Offizielle Ausschreibungsseite · Latest official notice: Änderung: KMU-innovativ: Medizintechnik

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 15. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.